HIV and ENT by Lubbe, DE
According to World Health Organisation (WHO) statistics for the year 2002,
there are an estimated 5.3 million South Africans living with HIV. Although south-
ern Africa is home only to 2% of the world’s population, the region accounts for
30% of people living with HIV worldwide.1
It has been well documented that 70 - 90% of patients with HIV will at some
stage present with an ENT manifestation of the disease. Most of them will initially
present to the general practitioner and it is important that the ENT manifestations
of HIV are recognised early and that appropriate management is instituted.
Antiretroviral therapy can prevent and cure most of these diseases, but as this
option is not readily available to the majority of South Africans we need to look
at alternative treatment.
HIV-positive patients will be included, knowingly or unknowingly, in all general 
practices and may present with a complaint totally unrelated to their underlying
disease or with an AIDS-defining opportunistic infection or malignancy.  Routine
organisms predominate when it comes to infections of the ear, nose and throat, 
which means that HIV-positive patients should be treated with the same antibiotic
as HIV-negative patients, based on the most likely organism responsible for that
specific  infection.  The most common ENT manifestations of HIV are listed in
Table I.
ORAL CAVITY MANIFESTATIONS
Contrary to medical training in the pre-HIV era, multiple lesions can be present 
simultaneously in those infected with HIV. Recent studies have proved that there is
a decreased appearance in the occurrence of buccal lesions in those on triple
antiretroviral therapy.2
Oral candidiasis is one of the earliest and most common findings suggesting
HIV infection and is characterised by a typical cottage cheese inflammatory
appearance. These patients usually still appear healthy, but if a known HIV-posi-
tive patient develops thrush, long-term survival appears to be diminished. Four
different types of oral candidiasis can be identified:
• Pseudomembranous candidiasis. This is the classic form identified by a white
plaque that can be scraped off, leaving an erythematous, bleeding base.
• Hyperplastic candidiasis. These lesions can easily be confused with leuko-
plakia or oral hairy leukoplakia since they appear as thick white plaques that
cannot be scraped off. If there is any doubt regarding the diagnosis, a biopsy
is indicated. 
• Atrophic candidiasis. This presents as flat atrophic lesions involving the oral
and oropharyngeal mucosa.
• Angular cheilitis. These are oral commissure erythematous lesions that can
involve the adjacent skin. 
Topical agents are usually effective in the early stages of HIV infection, but with 
advanced disease and increasing immune deficiency, systemic therapy (with flu-
conazole and rarely amphotericin B) may be indicated. Oesophageal or pharyn-
geal candidiasis is more common in this patient population and should be sus-
pected in patients with oral candidiasis who develop a severe sore throat or diffi-
culty in swallowing.  
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It has been well documented that 70 - 90% of patients with HIV will at some stage
present with an ENT manifestation of the disease.
Oral hairy leukoplakia (Fig. 1) is
a condition almost pathognomonic of
HIV infection and often indicates pro-
gression to AIDS. The lesion most fre-
quently appears on  the lateral aspect
of the tongue with a thick, vertically
correlated (‘hairy’) whitish plaque, 
very similar in appearance to the
hyperplastic type of oral candidiasis.
Potassium hydroxide (KOH) prepara-
tions of surface scrapings will identify
the mycelia or hyphae seen in candidi-
asis and can therefore be used to dif-
ferentiate between these two condi-
tions. A biopsy of the lesion will be
diagnostic of oral hairy leukoplakia.
The Epstein-Barr virus has been identi-
fied as the most likely causative agent.
Oral hairy leukoplakia is typically
asymptomatic and does not usually
require any treatment, but it is a signif-
icant finding because of its diagnostic
and prognostic implications. The
lesions have been successfully treated
with aciclovir (2 g/day), sulpha drugs,
zidovudine or topical retinoic acid
(Fig. 1).
Herpes simplex infections are
more common in those infected with
HIV, with herpes labialis being the
most common manifestation.  These
‘fever blisters’ are larger, more numer-
ous, recur more often and persist for
longer periods. Herpes simplex virus
type 1 (HSV-1) is most commonly
involved and usually begins as small
bullae that rupture and then coalesce.
It can extend onto the adjacent facial
skin and form giant herpetic lesions. If
the diagnosis is in doubt then smears
or scrapings should be taken before
starting treatment. Mild oral herpes
infections can usually be treated con-
servatively, but high-dose oral aciclovir
(up to 4 g/day) should be used for
more severe lesions. Aciclovir will only
be effective in eradicating the lesions
if started within the first few days of
infection. Prophylactic aciclovir can be
used in the severely immunocompro-
mised patient with frequent recur-
rences.
Periodontal disease, gingivitis
and necrotising gingivitis are
much more severe in the HIV-positive
patient and can produce significant
morbidity with extensive tissue destruc-
tion. HIV-associated gingivitis usually
begins with erythematous, bleeding
gums after minor trauma and can then
rapidly progress to a necrotising
process known as acute necrotising
ulcerative gingivitis (ANUG), a condi-
tion that has once again resurfaced in 
the HIV-positive population. It is there-
fore imperative that HIV-infected indi-
viduals practise good oral hygiene
and that even a mild gingivitis be
treated early and adequately.
Treatment consists of rinsing the mouth
with chlorhexidine solution, antibiotics
against Gram-negative anaerobes and
early referral to an oral surgeon if the
condition progresses. 
Recurrent aphthous ulcers are
frequently encountered in the HIV-posi-
tive patient and present as painful
ulcers on the non-keratinised unat-
tached oral mucosa. They vary in size
from 0.2 mm to > 6 mm.  Treatment is
aimed at symptomatic relief using anti-
septic mouthwashes, topical steroids
and topical anaesthetics. In cases of
large ulcerative lesions and frequent
recurrences a biopsy should be consid-
ered if lesions do not respond to treat-
ment.
AIDS patients have a much higher inci-
dence of developing oral cavity
Kaposi’s sarcoma and non-Hodgkin’s
lymphoma. 
Kaposi’s sarcoma (Fig. 2) is the
most common oral tumour in AIDS
patients and one of the AIDS-defining
illnesses. These dark, purple/pink
macular lesions can be found on 
any oral mucosal surface, but the
palate is involved in 95% of cases.
Although the diagnosis is usually easi-
ly made based on clinical findings, an
excisional biopsy is indicated, prefer-
ably from a cutaneous lesion, as these
lesions are vascular and can bleed 
HIV AND ENT
May 2004  Vol.22  No.5  CME 251
Table I. ENT manifestations of HIV
Oral Nose and paranasal Otological and 
sinuses neurotological Head and neck
• Recurrent Cutaneous lesions • Otitis externa • Generalised lymphadenopathy
aphthous ulcers • Kaposi’s sarcoma • Otitis media with • Neck mass 
• Candidiasis • Herpes simplex effusion Mycobacterium tuberculosis
• Herpes simplex • Herpes zoster • Eustachian tube Mycobacterium avium
• Gingivitis • Seborrhoeic dermatitis dysfunction Cryptococcosis
• Stomatitis Non-cutaneous • Kaposi’s sarcoma Histoplasmosis
• Periodontitis • Adenoid hypertrophy • Sensorineural Coccidioidomycosis
• Condylomata • Eustachian tube hearing loss • Parotid gland cyst
• Hairy leukoplakia obstruction • Bell’s palsy
• Kaposi’s sarcoma • Allergic rhinitis
• Non-Hodgkin’s • Acute AND chronic
lymphoma sinusitis
Fig. 1. Oral hairy leukoplakia (repro-
duced with permission from Professor
Jos Hille).
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profusely. Treatment is mostly pallia-
tive, as HIV-positive patients with
Kaposi’s sarcoma are already severely
immunocompromised and the eventual
cause of death is usually opportunistic
infections and not tumour effects.
Treatment also depends on whether
there is a solitary tumour or dissemi-
nated disease. Although Kaposi’s sar-
coma is very radiosensitive and
localised tumours respond well to low-
dose radiotherapy with a 
good palliative result, HIV-positive
patients appear to be more susceptible
to radiation-induced mucositis and
cannot tolerate wide-field radiation.
Alternative treatment options include
intralesional chemotherapy for solitary
lesions and systemic chemotherapy for 
disseminated disease. Systemic thera-
py causes further immunosuppression,
with an increased risk of opportunistic
infections. Laser and cryotherapy have
also been used for localised tumours.
Non-Hodgkin’s lymphoma is the
second most common AIDS-associated 
malignancy. The tumours are exophytic
and can involve the alveolar ridge,
palate, gingiva, sinonasal cavity,
orbit, neck and nearly any other site.
Most patients have extranodal disease
and 70% of cases have high-grade
disease, with a poor prognosis and
systemic chemotherapy options limited
by the already compromised 
immune system. The diagnosis must be
made by tissue biopsy if from an
extranodal site or by doing a com-
plete excisional biopsy from the low-
est, largest involved cervical lymph
node in the neck.
The association between squamous
cell carcinoma (SCC) of the head
and neck and HIV infection is still
controversial. It has been noted, how-
ever, that there are many young HIV
patients with no or moderate risk fac-
tors for SCC who present with this
condition of the oral cavity.3 SCC
seems to present at an earlier age and
tends to be more aggressive in HIV-
positive patients compared with HIV-
negative patients in the same age
group. This suggests that there might
be a relationship between SCC and
HIV infection, although there is as yet
little evidence to support this. The lat-
eral tongue is most frequently involved
and the lesion can be either infiltrative
or exophytic. Diagnosis is made on
biopsy and management of the HIV- 
positive patient with SCC should be
no different from that of an HIV-nega-
tive patient. Unless the patient is surgi-
cally unfit or severely immunocompro-
mised, s/he will benefit from surgical
resection and neck dissection, as con-




Between 40% and 70% of patients
with AIDS will present with allergic
rhinitis, sinusitis, a blocked nose or
symptoms suggesting a possible
sinonasal malignancy. The most com-
mon sinonasal complaint is that of a
blocked nose, the most likely causes
being adenoidal hypertrophy and
allergic rhinitis. HIV-infected individu-
als often suffer from other common ill-
nesses, such as TB, which can present
with unusual manifestations of the 
disease (Fig. 3). 
Adenoidal hypertrophy will pres-
ent as persistent nasal obstruction. In
the adult patient this demands further
investigation and the possibility of HIV
infection must be entertained.  In HIV-
positive patients enlarged adenoids
are most commonly due to lymphoid
hyperplasia and generalised lym-
phadenopathy and enlarged tonsils
are frequently part of the clinical pic-
ture. The aetiology is thought to be
related to B-cell activation by HIV,
Epstein-Barr virus or cytomegalovirus.
Otitis media with effusion (OME),
causing a conductive hearing loss,
often follows owing to obstruction of
the Eustachian tubes by the lymphoid
mass in the postnasal space.
Lymphoma, especially high-grade B-
cell lymphoma, needs to be excluded.
The diagnosis of a postnasal mass can
be made by doing a posterior
rhinoscopy using an angled mirror, a
lateral radiograph of the neck or a
flexible nasopharyngoscope, the last
being the method of choice used by
ENT surgeons. A biopsy of the mass
can then be taken either under local
or general anaesthesia. For lymphoid
hyperplasia, an adenoidectomy is fre-
quently done to relieve symptoms of
nasal obstruction and OME.
Lymphoma is treated with systemic
chemotherapy, and radiotherapy is
given if the tumour causes any mass
effect. 
Allergic rhinitis is very common in
the HIV-positive population. Although
cellular immunity is depressed, there
seems to be increased polyclonal B-
cell activation with increased circulat-
ing immune complexes and increased
levels of IgE.  These high levels of IgE
then lead to increased IgE-mediated
allergic symptoms. Patients present
with sneezing, watery rhinorrhoea and
a blocked nose. Treatment consists of
allergen avoidance, topical steroids
and oral antihistamines.
Acute, recurrent and chronic rhinosi-
nusitis occurs in 20 - 68% of HIV-
infected patients. Predisposing factors
include allergic rhinitis, with the oede-
matous mucosa leading to obstruction
of the sinus ostia, and decreased local
and systemic immunity. The microbiolo-
gy is similar to that found in the HIV-
negative population, with the excep-
tion of two atypical opportunistic
organisms, Pseudomonas aeruginosa
and Aspergillus fumigatus. Initial man-
Fig. 2. Kaposi’s sarcoma of the
palate (reproduced with permission
from Professor Jos Hille).
Fig. 3. An old disease (TB) with an
unusual presentation.
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agement should be restricted to the
use of first-line drugs such as 
amoxicillin or amoxiclav.
Mucormycosis, although found in the
neutropenic immunocompromised host,
is not a common disease in the HIV-
infected patient. The reason for this is
that the HIV-positive patient does not
become neutropenic until the final
stages of the disease process.  
NECK MANIFESTATIONS
Enlarging neck masses frequently
occur in the HIV-infected population
and up to 90% of patients with an
ENT manifestation will present with a
neck mass as well. The diagnostic
approach differs slightly from that of
the HIV-negative patient where investi-
gations are mostly aimed at excluding
a malignancy. The differential diagno-
sis of a neck mass in the HIV-positive
patient can be broadly divided into






denopathy is present in up to 70%
of patients in the initial period after
seroconversion and can be defined in
adults as lymphadenopathy 
greater than 1 cm, of unexplained
aetiology and involving 2 or more
extra-inguinal sites for longer than 3
months.4 Indications for further investi-
gations and fine-needle aspiration 
cytology (FNAC) include the following:
rapidly enlarging lymph nodes, a
dominant node, asymmetrical lym-
phadenopathy, firm non-mobile nodes
and recent weight loss. 
Parotid gland enlargement is
commonly encountered in HIV-infected
adults and children who are not on
antiretroviral therapy. HIV-associated
cystic lympho-epithelial disease
(benign lympho-epithelial cysts) is a
disease process unique to HIV-infected
individuals and the aetiology is
thought to be related to a lymphoid
response to HIV infection.  Patients
usually present with bilateral, painless
parotomegaly and, except for the 
cosmetic deformity, these lesions are
completely asymptomatic. The natural
progression of the disease is unknown.
Management of these lesions includes
confirming the diagnosis with ultra-
sound or FNAC. Ultrasound clearly
shows multiple cystic lesions within the
parotid gland. Treatment is guided by
the severity of the cosmetic deformity 
and includes antiretroviral therapy,
aspiration of the cysts with tetracycline
sclerosis and low-dose radiotherapy. 
Infectious processes causing cervi-
cal lymphadenopathy include tubercu-
losis, non-tuberculous mycobacterial
infections, toxoplasmosis, bacterial
lymphadenitis and fungal infections. 
OTOLOGICAL
MANIFESTATIONS
Ear manifestations occur less frequent-
ly than the abovementioned ENT mani-
festations. HIV-infected individuals do
not have a higher incidence of otitis
externa and they are not more prone
to develop necrotising otitis externa
when compared with other immuno-
compromised patients such as diabet-
ics.
The incidence of OME is higher in the
HIV population than in the general
population, and if an adult patient
presents with bilateral middle ear effu-
sions the possibility of HIV infection
must be considered. Patients with
OME must be referred to an ENT sur-
geon for further investigations and
exclusion of a postnasal lesion
obstructing the eustachian tubes.
Treatment is still controversial, but
includes the insertion of ventilation
tubes and an adenoidectomy if indi-
cated. 
Sensorineural hearing loss
occurs in the HIV-infected patient and
the causes include a direct effect of
the neurotropic virus on the cochlear
nerve, syphilis, and cryptococcal
meningitis. Investigations include a
complete audiology work-up, ENT
examination, laboratory tests to
exclude syphilis, and imaging if indi-
cated. Cerebrospinal fluid is sampled
in some instances to detect Treponema
pallidum and the cryptococcal anti-
gen.  
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Routine organisms predominate
when it comes to infections of the
ear, nose and throat.
HIV-positive patients should initially
be treated with the same antibiotic
as HIV-negative patients.
Multiple oral lesions can be present
simultaneously. 
Oral candidiasis and rhinosinusitis
are the commonest ENT manifesta-
tions of HIV.
Oesophageal candidiasis must be
suspected in patients with increas-
ing dysphagia and odynophagia.
Oral hairy leukoplakia is a condi-
tion almost pathognomonic of HIV
infection and often indicates pro-
gression to AIDS.
Kaposi’s sarcoma is the most com-
mon HIV-associated oral tumour
and predominantly occurs on the
palate. 
HIV-associated cystic lympho-epithe-
lial disease of the parotid is a dis-
ease process unique to HIV-infected
individuals.
OME in the adult patient must be
investigated and the HIV status of
the patient ascertained.
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